New direct thrombin inhibitor becomes available.
Thompson
Cheryl A
CA
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D006629:Hirudins / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D011183:Postoperative Complications / Q000517:prevention & control; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013917:Thrombin / Q000037:antagonists & inhibitors*; D014481:United States; D014486:United States Food and Drug Administration
D000925:Anticoagulants; D006629:Hirudins; D011994:Recombinant Proteins; D013917:Thrombin; C060225:desirudin